Ignite Creation Date:
2025-12-26 @ 11:50 AM
Ignite Modification Date:
2025-12-26 @ 11:50 AM
Study NCT ID:
NCT01283516
Status:
COMPLETED
Last Update Posted:
2019-03-15
First Post:
2011-01-24
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Dose Escalation/Expansion Study of LDK378 in Patients With Tumors Characterized by Genetic Abnormalities in Anaplastic Lymphoma Kinase
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-01-24
Start Date Type:
ACTUAL
Primary Completion Date:
2016-05-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-05-03
Completion Date Type:
ACTUAL
First Submit Date:
2011-01-24
First Submit QC Date:
None
Study First Post Date:
2011-01-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-05-29
Results First Submit QC Date:
None
Results First Post Date:
2014-08-11
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-11-28
Last Update Post Date:
2019-03-15
Last Update Post Date Type:
ACTUAL